Apyx Medical Corporation (APYX)

NASDAQ: APYX · IEX Real-Time Price · USD
1.87
+0.05 (2.75%)
At close: Dec 5, 2022 4:00 PM
1.83
-0.04 (-2.14%)
After-hours: Dec 5, 2022 4:23 PM EST
2.75%
Market Cap 62.97M
Revenue (ttm) 48.72M
Net Income (ttm) -19.14M
Shares Out 34.57M
EPS (ttm) -0.47
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 195,278
Open 1.9
Previous Close 1.82
Day's Range 1.77 - 1.9
52-Week Range 1.31 - 14.51
Beta 1.52
Analysts Buy
Price Target 9.18 (+390.9%)
Earnings Date Nov 10, 2022

About APYX

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and... [Read more]

Industry Health Care Equipment & Supplies
IPO Date Jan 1, 1987
CEO Robert Gershon
Employees 272
Stock Exchange NASDAQ
Ticker Symbol APYX
Full Company Profile

Financial Performance

In 2021, Apyx Medical's revenue was $48.52 million, an increase of 75.08% compared to the previous year's $27.71 million. Losses were -$15.17 million, 27.5% more than in 2020.

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for APYX stock is "Buy." The 12-month stock price forecast is 9.18, which is an increase of 390.91% from the latest price.

Price Target
$9.18
(390.91% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Apyx Medical Corporation to Participate in the Piper Sandler 34th Annual Healthcare Conference

CLEARWATER, Fla.--( BUSINESS WIRE )--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®,...

1 week ago - Business Wire

Apyx Medical (APYX) Reports Q3 Loss, Misses Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of -41.67% and 24.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

3 weeks ago - Zacks Investment Research

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2022 Financial Results on November 10, 2022

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, t...

2 months ago - Business Wire

'BOTCHED' TV STAR DR. PAUL NASSIF AMONG TOP U.S. PLASTIC SURGEONS USING RENUVION® HELIUM PLASMA TECHNOLOGY IN COSMETI...

Doctors Attest to Advanced Energy Technology Device's Transformative Solutions to Achieve Desired Results in Patients CLEARWATER, Fla. , Sept. 13, 2022 /PRNewswire/ -- Apyx Medical Corporation (NASDAQ: ...

2 months ago - PRNewsWire

Apyx Medical Corporation to Participate in the Lake Street Best Ideas Growth Conference

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, a...

2 months ago - Business Wire

Apyx Medical Corporation Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, t...

3 months ago - Business Wire

APYX SHAREHOLDER ALERT: Jakubowitz Law Reminds Apyx Shareholders of a Lead Plaintiff Deadline of August 5, 2022

NEW YORK , Aug. 5, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Apyx Medical Corporation (NASDAQ: APYX). To recei...

4 months ago - PRNewsWire

DEADLINE TODAY: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 to Conta...

Los Angeles, California--(Newsfile Corp. - August 5, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Apyx Medical Corporat...

4 months ago - Newsfile Corp

Apyx Class Action: Levi & Korsinsky Reminds Apyx Medical Corporation Investors of the Pending Class Action Lawsuit wi...

New York, New York--(Newsfile Corp. - August 4, 2022) - Levi & Korsinsky, LLP notifies investors in Apyx Medical Corporation (NASDAQ: APYX) ("Apyx" or the "Company") of a class action securities lawsuit...

4 months ago - Newsfile Corp

APYX DEADLINE TOMORROW: ROSEN, A TOP RANKED FIRM, Encourages Apyx Medical Corporation Investors With Losses to Secure...

New York, New York--(Newsfile Corp. - August 4, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Apyx Medical Corporation (NASDAQ: APYX) between Ma...

4 months ago - Newsfile Corp

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Apyx Medic...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming August 5, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors ...

4 months ago - Business Wire

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 ...

LOS ANGELES--(BUSINESS WIRE)---- $APYX #APYX--The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 to Contact the Firm

4 months ago - Business Wire

DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 to Co...

Los Angeles, California--(Newsfile Corp. - August 4, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Apyx Medical Corporat...

4 months ago - Newsfile Corp

APYX LAWSUIT ALERT: Levi & Korsinsky Notifies Apyx Medical Corporation Investors of a Class Action Lawsuit and Upcomi...

NEW YORK , Aug. 4, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Apyx Medical Corporation ("Apyx" or the "Company") (NASDAQ: APYX) of a class action securities lawsuit. CLASS DEFINITI...

4 months ago - PRNewsWire

FRIDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 ...

Los Angeles, California--(Newsfile Corp. - August 3, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Apyx Medical Corporat...

4 months ago - Newsfile Corp

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Apyx Medical Corporation of a Class Action Lawsuit and...

NEW YORK , Aug. 3, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Apyx Medical Corporation. Shareholders who purchased shares of APYX during the class period list...

4 months ago - PRNewsWire

APYX Investors Have Opportunity to Lead Apyx Medical Corporation Securities Fraud Lawsuit

LOS ANGELES , Aug. 2, 2022 /PRNewswire/ --  Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit agains...

4 months ago - PRNewsWire

FRIDAY DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,00...

Los Angeles, California--(Newsfile Corp. - August 2, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Apyx Medical Corporat...

4 months ago - Newsfile Corp

APYX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 5, 2022 in the Class Action Filed on Beh...

NEW YORK , Aug. 2, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Apyx Medical Corporation (NASDAQ: APYX) alleging that the C...

4 months ago - PRNewsWire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apyx Medical Corporation - APYX

NEW YORK , Aug. 1, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Apyx Medical Corporation ("Apyx" or the "Company") (NASDAQ: APYX). Such investors are advised to ...

4 months ago - PRNewsWire

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Apyx Investors of a Lead Plaintiff Deadline of August 5, 2022

NEW YORK , Aug. 1, 2022 /PRNewswire/ -- Attention Apyx Medical Corporation ("Apyx") (NASDAQ: APYX) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on beh...

4 months ago - PRNewsWire

APYX FINAL DEADLINE FRIDAY: ROSEN, A RESPECTED AND LEADING FIRM, Encourages Apyx Medical Corporation Investors to Sec...

New York, New York--(Newsfile Corp. - July 30, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Apyx Medical Corporation (NASDAQ: APYX) between May...

4 months ago - Newsfile Corp

APYX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 5, 2022 in the Class Action Filed on Beh...

New York, New York--(Newsfile Corp. - July 29, 2022) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Apyx Medical Corporation (NASDAQ: APYX) alle...

4 months ago - Newsfile Corp

APYX FINAL DEADLINE AUGUST 5: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Apyx Medical Corporation Investors with ...

NEW YORK , July 29, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Apyx Medical Corporation (NASDAQ: APYX) between May 12, 2021 and ...

4 months ago - PRNewsWire